Details for 2019845466

Up to date per 02.04.2026

Actions

Title / Product Name

SYNERGISTISCHE ANTITUMORWIRKUNG EINES BCL-2-INHIBITORS IN KOMBINATION MIT RITUXIMAB UND/ODER BENDAMUSTIN ODER EINES BCL-2-INHIBITORS IN KOMBINATION MIT CHOP

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019845466

EP Publication Number

3672591

E-Number

1656467

Language

PCT Number

CN19097028

Publication Date

01.07.2020 A

14.02.2024 B1

Registration Date

14.02.2024

AT Publication Date

15.03.2024

Application Date

22.07.2019

Registration Number

Priorities

31.07.2018

201810867252

IPC

A61K 31/4184 20060101AFI20230904BHEP

Maximum Duration of Protection

22.07.2039

Owner

Ascentage Pharma (Suzhou) Co., Ltd.Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215000CN

Representative

No representatives present

Inventor

YANG, DajunUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

ZHAI, YifanUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

WANG, GuangfengUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN